A previous study indicated that a combined high ACSL4 level and low-dose 256-slice spiral CT may be a potential biomarker for the screening of early lung cancer, and high ACSL4 indicates a better prognosis than low ACSL4 levels [19]. This evidence concerns the gene ACSL4 and lung carcinoma.